3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Carcinoma, Renal Cell
6
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Transitional Cell
3
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Hematologic Neoplasms
2
Carcinoma, Basal Cell
2
Xeroderma Pigmentosum
1
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Somatostatinoma
1
Sjogren's Syndrome
1
Seminoma
1
Scleroderma, Systemic
1
Sarcoma
1
Recurrent Squamous Cell Lung Carcinoma
1
Rectal Neoplasms
1
Rare Diseases
1
Psoriasis
1
Pseudomyxoma Peritonei
1
Pheochromocytoma
1
Interventions
pembrolizumab
3
Pemetrexed
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Carboplatin
2
trifluridine tipiracil drug combination
1
tislelizumab
1
sacituzumab govitecan
1
SYS6006 COVID-19 vaccine
1
Irinotecan
1
Drug Therapy
1
Docetaxel
1
Cetuximab
1
Bevacizumab
1
Antiemetics
1
ASP1570
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
CTLA-4 Antigen
×
30 days
×
Clear all
No trials found.